We partner with early- and growth-stage companies, corporations, venture capital/private equity firms, technology organizations, and mission-based organizations who are leading the charge to improve health.
We work with our clinical teams to identify problems and opportunities to transform care and then scan the market to find those companies that will deliver the greatest impact. We provide access to capital, data and clinical expertise to help these companies grow into scalable solutions that will dramatically improve the delivery of care and health in our communities and the world.
Employees: 11-50
Founded date: 2019
Investment Type: Venture Capital
Portfolio 19
Date | Name | Website | Total Raised | Location |
- | Jvion | jvion.com | - | United Sta... |
- | Shields He... | shieldshea... | - | - |
- | Redox | redoxengin... | $94.5M | United Sta... |
- | Syapse | syapse.com | $201M | United Sta... |
- | Recursion ... | recursionp... | $897.25M | United Sta... |
- | Omada Heal... | omadahealt... | $584.5M | United Sta... |
- | Sera Progn... | seraprogno... | $165.3M | United Sta... |
- | PierianDx | pieriandx.... | $83.75M | United Sta... |
- | Armis | armis.com | $412M | United Sta... |
- | Ciitizen | ciitizen.c... | $20M | United Sta... |
Show more
Mentions in press and media 2
Date | Title | Description | Source |
27.02.2024 | Freenome scores $254M to advance its cancer-detection blood ... | The San Francisco company readies to reveal its first clinical study results in the near term When i... | vator.tv/n... |
15.07.2020 | GYANT Raises $13.6M for AI-Enabled Digital Front Door Soluti... | What You Should Know: – GYANT raises $13.6M in Series A funding for AI-enabled digital front door so... | hitconsult... |